128 related articles for article (PubMed ID: 36351503)
41. Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study.
Salem HF; Kharshoum RM; Abou-Taleb HA; Naguib DM
AAPS PharmSciTech; 2019 May; 20(5):181. PubMed ID: 31049748
[TBL] [Abstract][Full Text] [Related]
42. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
[TBL] [Abstract][Full Text] [Related]
43. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
[TBL] [Abstract][Full Text] [Related]
44. Intranasal delivery of insulin by self-emulsified nanoemulsion system: In vitro and in vivo studies.
Shah D; Guo Y; Ban I; Shao J
Int J Pharm; 2022 Mar; 616():121565. PubMed ID: 35150847
[TBL] [Abstract][Full Text] [Related]
45. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
[TBL] [Abstract][Full Text] [Related]
46. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
Md S; Haque S; Fazil M; Kumar M; Baboota S; Sahni JK; Ali J
Expert Opin Drug Deliv; 2014 Jun; 11(6):827-42. PubMed ID: 24655115
[TBL] [Abstract][Full Text] [Related]
47. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):307-15. PubMed ID: 24845478
[TBL] [Abstract][Full Text] [Related]
49. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
Mittal D; Md S; Hasan Q; Fazil M; Ali A; Baboota S; Ali J
Drug Deliv; 2016; 23(1):130-9. PubMed ID: 24786489
[TBL] [Abstract][Full Text] [Related]
50. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K
Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333
[TBL] [Abstract][Full Text] [Related]
51. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel.
Chen X; Zhi F; Jia X; Zhang X; Ambardekar R; Meng Z; Paradkar AR; Hu Y; Yang Y
J Pharm Pharmacol; 2013 Jun; 65(6):807-16. PubMed ID: 23647674
[TBL] [Abstract][Full Text] [Related]
52. Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers.
Mao Y; Yuan W; Gai J; Zhang Y; Wu S; Xu EY; Wang L; Zhang X; Guan J; Mao S
Int J Pharm; 2024 Apr; 654():123930. PubMed ID: 38387820
[TBL] [Abstract][Full Text] [Related]
53. Antipsychotic Potential and Safety Profile of TPGS-Based Mucoadhesive Aripiprazole Nanoemulsion: Development and Optimization for Nose-To-Brain Delivery.
Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
J Pharm Sci; 2021 Apr; 110(4):1761-1778. PubMed ID: 33515583
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
[TBL] [Abstract][Full Text] [Related]
55. Nose-to-brain delivery of levetiracetam after intranasal administration to mice.
Gonçalves J; Bicker J; Gouveia F; Liberal J; Oliveira RC; Alves G; Falcão A; Fortuna A
Int J Pharm; 2019 Jun; 564():329-339. PubMed ID: 31015006
[TBL] [Abstract][Full Text] [Related]
56. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
[TBL] [Abstract][Full Text] [Related]
57. Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery.
El Taweel MM; Aboul-Einien MH; Kassem MA; Elkasabgy NA
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834242
[TBL] [Abstract][Full Text] [Related]
58. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
Ramreddy S; Janapareddi K
Drug Dev Ind Pharm; 2019 Jan; 45(1):147-158. PubMed ID: 30230386
[TBL] [Abstract][Full Text] [Related]
59. Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies.
Nair AB; Chaudhary S; Shah H; Jacob S; Mewada V; Shinu P; Aldhubiab B; Sreeharsha N; Venugopala KN; Attimarad M; Shah J
Gels; 2022 May; 8(6):. PubMed ID: 35735686
[TBL] [Abstract][Full Text] [Related]
60. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
